Placebo News and Research

RSS

Zinbryta gets FDA approval for treating adults with relapsing forms of MS

The U.S. Food and Drug Administration today approved Zinbryta (daclizumab) for the treatment of adults with relapsing forms of multiple sclerosis (MS). Zinbryta is a long-acting injection that is self- administered by the patient monthly.

28 May 2016

Study explores how lighting impacts healthy food choices

Dining in dimly lit restaurants has been linked to eating slowly and ultimately eating less than in brighter restaurants, but does lighting also impact how healthfully we order?

27 May 2016

First clinical trial to study use of Chinese Herbal Medicines in treating RUTIs

Researchers at the University of Southampton are to study the use of Chinese Herbal Medicines in treating recurrent urinary tract infections (RUTIs), in the first clinical trial of its kind in the UK.

25 May 2016

Transplanted human stool may offer treatment hope for ulcerative colitis patients

Patients with ulcerative colitis (UC) may improve their symptoms with a transplantation of healthy stool from donors, according to Australian researchers. The findings were presented by Dr Sudarchan Paramsothy MD, a gastroenterologist from the University of New South Wales, Australia at the Digestive Disease Week conference in San Diego, California between the 21st to 24th May.

24 May 2016

Early aspirin benefits after minor stroke 'underestimated'

A meta-analysis of individual patient data has thrown light on the benefits of aspirin for secondary prevention in patients with ischaemic stroke.

19 May 2016

SUSTAIN study to test effect of high-dose selenium on recovery of cardiac surgery patients

Queen's University researcher Daren Heyland is leading a study that aims to reduce the risk of complications and improves recovery of cardiac surgery patients.

19 May 2016

High doses of vitamin D supplements could lead to fewer birth complications but reduce fertility

New research has established that high doses of vitamin D supplements can lead to fewer complications during childbirth but reduce a woman's chances of getting pregnant in the first place.

19 May 2016

Early high-dose rhEPO fails to improve neurodevelopment in very preterm infants

Very preterm infants do not gain protection against neurodevelopmental delay with early prophylactic high-dose recombinant human erythropoietin, researchers report.

19 May 2016

Melatonin can be of great value for elderly people suffering from hypertension

The older we get, the more likely our circadian rhythms are disrupted. For example, blood pressure (BP), not only tends to increase but as well become more irregular. Luckily, as we show in our research, melatonin helps to ameliorate both trends.

18 May 2016

Smokers who use novel nicotine inhaler twice as likely to quit smoking

A study by researchers at New Zealand's University of Otago, Wellington shows that smokers who used a nicotine inhaler were twice as likely to quit smoking as smokers using a placebo inhaler.

17 May 2016

Magic mushroom compound may offer potential new way for antidepressant research

Psilocybin – a hallucinogenic compound derived from magic mushrooms – may offer a possible new avenue for antidepressant research, according to a new study published in The Lancet Psychiatry today.

17 May 2016

Pluristem completes enrollment in Phase II intermittent claudication trial

Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, today announced it has completed the planned enrollment of 150 patients in a global Phase II trial of its PLacental eXpanded (PLX)-PAD cells for the treatment of intermittent claudication (IC), a peripheral artery disease (PAD). The double blind, randomized, placebo controlled trial enrolled 50 patients since October 2015 in the U.S., Germany, Israel, and South Korea.

16 May 2016

Boehringer Ingelheim presents new data on OFEV® (nintedanib) in idiopathic pulmonary fibrosis (IPF)

New analyses presented at the American Thoracic Society’s 2016 annual conference (ATS 2016) further add to the efficacy and safety profile of OFEV® (nintedanib) in idiopathic pulmonary fibrosis (IPF).

16 May 2016

Clinical study shows sitagliptin drug not effective in treating NAFLD

A diabetes medication described in some studies as an effective treatment for nonalcoholic fatty liver disease (NAFLD) works no better than a placebo, report researchers at University of California San Diego School of Medicine, after conducting the first randomized, double-blind, controlled clinical trial of sitagliptin, an oral antihyperglycemic marketed by Merck & Co. under the name Januvia.

13 May 2016

Placebo News and Research

Zinbryta gets FDA approval for treating adults with relapsing forms of MS

Study explores how lighting impacts healthy food choices

First clinical trial to study use of Chinese Herbal Medicines in treating RUTIs

Transplanted human stool may offer treatment hope for ulcerative colitis patients

Early aspirin benefits after minor stroke 'underestimated'

SUSTAIN study to test effect of high-dose selenium on recovery of cardiac surgery patients

High doses of vitamin D supplements could lead to fewer birth complications but reduce fertility

Early high-dose rhEPO fails to improve neurodevelopment in very preterm infants

Melatonin can be of great value for elderly people suffering from hypertension

Smokers who use novel nicotine inhaler twice as likely to quit smoking

Magic mushroom compound may offer potential new way for antidepressant research

Pluristem completes enrollment in Phase II intermittent claudication trial

Boehringer Ingelheim presents new data on OFEV® (nintedanib) in idiopathic pulmonary fibrosis (IPF)

Clinical study shows sitagliptin drug not effective in treating NAFLD

Combination of two compounds found in red grapes, oranges could treat diseases

Psychological therapies may help people who self-harm, study finds

Could oral supplements affect teenage behavior? An interview with Prof. Stein and Dr Tammam

Repeat, low-dose ketamine infusions may quickly reduce suicidal thoughts in depressed outpatients

Transcranial direct current stimulation proves effective for binge-eating disorder

More evidence for combination therapy benefits in PAH

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News